The contribution of incretin hormones, especially glucagon-like peptide-1 (GLP-1) (Vilsbøll et al., 2003), to the total insulin responses of healthy volunteer and T2DM patients is about 70% and 36% (Nauck et al., 1986), respectively. The gene discussed is GCG; the disease is type 2 diabetes mellitus.